Page 2408

at no cost to the provider;

(2) the administration of a vaccine product to a recipient under 21 years of age;

(3) for a recipient 21 years of age or older, the following vaccine products, unless they are available at no cost to the provider, and the administration of those vaccine products, regardless of whether they are available at no cost to the provider:

(A) Hepatitis A;

(B) Hepatitis B;

(C) Herpes Zoster (Shingles);

(D) Human Papillomavirus;

(E) Measles, Mumps, and Rubella (MMR);

(F) Meningococcal;

(G) Pneumococcal;

(H) seasonal Influenza;

(I) Tetanus Diphtheria (Td);

(J) Tetanus, Diphtheria, and Acellular Pertussis (Tdap);

(K) Varicella (Chickenpox);

(L) Haemophilus Influenzae Type B;

(M) post-exposure rabies vaccine or immune globulin;

(N) pandemic influenza;

(O) a vaccine product, and administration of a vaccine product, related to